SGMS2 and pancreatic ductal adenocarcinoma: Research has demonstrated a significant association between the expression of SGMS2 mRNA and the presence of tumor-associated macrophages (TAMs), as well as a negative impact on the prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) [23].